APOL1-Associated glomerular disease among African-American children: A collaboration of the chronic kidney disease in children (CKiD) and nephrotic syndrome study network (NEPTUNE) cohorts

Nephrology Dialysis Transplantation

Volumn 32, Issue 6, 2017, Pages 983-990

  Ng, Derek K ^a   Robertson, Catherine C ^b   Woroniecki, Robert P ^c   Limou, Sophie ^d   Gillies, Christopher E ^b   Reidy, Kimberly J ^e   Winkler, Cheryl A ^d   Hingorani, Sangeeta ^f   Gibson, Keisha L ^g   Hjorten, Rebecca ^e   Sethna, Christine B ^h   Kopp, Jeffrey B ⁱ   Moxey Mims, Marva ⁱ   Furth, Susan L ^j   Warady, Bradley A ^k   Kretzler, Matthias ^b   Sedor, John R ^l   Kaskel, Frederick J ^e   Sampson, Matthew G ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Renaissance School of Medicine at Stony Brook University   (United States)

^d FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^e MONTEFIORE MEDICAL CENTER   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

^h Division of Hematology Oncology and Cellular Therapy   (United States)

ⁱ NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^j CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^k CHILDREN S MERCY HOSPITAL   (United States)

^l CASE WESTERN RESERVE UNIVERSITY   (United States)

more..

Author keywords

Apol1; Epidemiology; Fsgs; Nephrotic syndrome; Pediatrics

Indexed keywords

ADOLESCENT; AFRICAN AMERICAN; ALPORT SYNDROME; ANAPHYLACTOID PURPURA; APOL1 GENE; ARTICLE; CHRONIC GLOMERULONEPHRITIS; COHORT ANALYSIS; COMPLEMENT COMPONENT C1Q NEPHROPATHY; CONGENITAL NEPHROTIC SYNDROME; CONTROLLED STUDY; DIFFUSE PROLIFERATIVE GLOMERULONEPHRITIS; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLOMERULOPATHY; HEMOLYTIC UREMIC SYNDROME; HUMAN; IDIOPATHIC CRESCENTIC GLOMERULONEPHRITIS; IMMUNE COMPLEX NEPHRITIS; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY CALCIFICATION; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS TYPE II; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE DISEASE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SICKLE CELL ANEMIA; SICKLE CELL NEPHROPATHY; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC IMMUNOLOGICAL DISEASE; CHILD; COMPARATIVE STUDY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; NEPHROTIC SYNDROME; ONSET AGE; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; UNITED STATES;

APOL1 PROTEIN, HUMAN; APOLIPOPROTEIN L1;

ADOLESCENT; AFRICAN AMERICANS; AGE OF ONSET; APOLIPOPROTEIN L1; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; NEPHROTIC SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; UNITED STATES;

EID: 85028289227     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfw061     Document Type: Article

References (28)

1. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845.
2. Tzur S, Rosset S, Shemer R et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to theMYH9 gene. Hum Genet 2010; 128: 345-350.
3. Kopp JB, Nelson GW, Sampath K et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-Associated nephropathy. J Am Soc Nephrol 2011; 22: 2129-2137.
4. Kruzel-Davila E, Wasser WG, Aviram S et al. APOL1 nephropathy: from gene to mechanisms of kidney injury. Nephrol Dial Transplant 2016; 31: 349-358.
5. Sampson MG, Robertson CC, Martini S et al. Integrative genomics identifies novel associations with APOL1 risk genotype in African American NEPTUNE subjects. J Am Soc Nephrol 2016; 27: 814-823.
6. Kopp JB, Winkler CA, Zhao X et al. Clinical features and histology of apolipoprotein L1-Associated nephropathy in the FSGS clinical trial. J Am Soc Nephrol 2015; 26: 1443-1448.
7. Parsa A, Kao WH, Xie D et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 2013; 369: 2183-2196.
8. Freedman BI, Langefeld CD, Andringa KK et al. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol 2014; 66: 390-396.
9. Foster MC, Coresh J, Fornage M et al. APOL1 variants associate with increased risk of CKD among African Americans. J Am Soc Nephrol 2013; 24: 1484-1491.
10. Hoy WE, Hughson MD, Kopp JB et al. APOL1 risk alleles are associated with exaggerated age-related changes in glomerular number and volume in African-American adults: An autopsy study. J Am Soc Nephrol 2015; 26: 3179-3189.
11. Anyaegbu EI, Shaw AS, Hruska KA et al. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease. Pediatr Nephrol 2015; 30: 983-989.
12. Furth SL, Cole SR, Moxey-Mims M et al. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 2006; 1: 1006-1015.
13. Gadegbeku CA, Gipson DS, Holzman LB et al. Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int 2013; 83: 749-756.
14. Alkalay AL, Graham JM Jr, Pomerance JJ. Evaluation of neonates born with intrauterine growth retardation: Review and practice guidelines. J Perinatol 1998; 18: 142-151.
15. Schwartz GJ, Munoz A, Schneider MF et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629-637.
16. Sampson MG, Gillies CE, Robertson CC et al. Using population genetics to interrogate the monogenic nephrotic syndrome diagnosis in a case cohort. J Am Soc Nephrol 2015; (in press).
17. Hodgin JB, Rasoulpour M, Markowitz GS et al. Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2009; 4: 71-76.
18. Papeta N, Kiryluk K, Patel A et al. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol 2011; 22: 1991-1996.
19. Kambham N, Markowitz GS, Valeri AM et al. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 2001; 59: 1498-1509.
20. Greenbaum LA, Munoz A, Schneider MF et al. The association between abnormal birth history and growth in children with CKD. Clin J Am Soc Nephrol 2011; 6: 14-21.
21. Hughson M, Farris AB III, Douglas-Denton R et al. Glomerular number and size in autopsy kidneys: The relationship to birth weight. Kidney Int 2003 63: 2113-2122.
22. Lackland DT, Egan BM, Fan ZJ et al. Low birth weight contributes to the excess prevalence of end-stage renal disease in African Americans. J Clin Hypertens 2001; 3: 29-31.
23. Vikse BE, Irgens LM, Leivestad T et al. Low birth weight increases risk for end-stage renal disease. J Am Soc Nephrol 2008; 19: 151-157.
24. Ikezumi Y, Suzuki T, Karasawa T et al. Low birthweight and premature birth are risk factors for podocytopenia and focal segmental glomerulosclerosis. Am J Nephrol 2013; 38: 149-157.
25. Rodriguez MM, Gomez A, Abitol C et al. Comparative renal histomorphometry: A case study of oligonephropathy of prematurity. Pediatr Nephrol 2005; 20: 945-949.
26. Rodriguez MM et al. Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatr Dev Pathol 2004; 7: 17-25.
27. Bruggeman LA, Wu Z, Luo L et al. APOL1-G0 or APOL1-G2 transgenic models develop preeclampsia but not kidney disease. J Am Soc Nephrol doi:10.1681/ASN.2015111220.
28. Flynn JT, Ng D, Chan GJ et al. The effect of abnormal birth history on ambulatory blood pressure and disease progression in children with chronic kidney disease. J Pediatr 2014; 165: 154-162 .e1.